Miracle Mile Advisors’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-40,000
Closed -$108K 729
2025
Q1
$108K Buy
40,000
+15,000
+60% +$56.3K ﹤0.01% 629
2024
Q4
$59K Sell
25,000
-15,000
-38% -$39.9K ﹤0.01% 625
2024
Q3
$94.8K Buy
40,000
+10,000
+33% +$22K ﹤0.01% 512
2024
Q2
$58.5K Buy
+30,000
New +$102K ﹤0.01% 490

Other funds holding GNLX

Miracle Mile Advisors's GNLX Position: Q2 2025 in Review

Miracle Mile Advisors sold out of Genelux (GNLX) in Q2 2025, closing a stake of 40,000 shares — an estimated $108K sold.

Miracle Mile Advisors first reported a position in GNLX in Q2 2024 and held it in 4 quarters. The position peaked at $108K in Q1 2025. 61 funds tracked by Wall St. Rank hold GNLX as of Q2 2025.

  • Miracle Mile Advisors reported no remaining Genelux position as of Q2 2025 after selling out during the quarter.
  • Miracle Mile Advisors sold 40,000 Genelux shares in Q2 2025, an estimated $108K.
  • Miracle Mile Advisors first reported a position in Genelux in Q2 2024 and held it in 4 quarters.
  • Miracle Mile Advisors's Genelux position peaked at $108K in Q1 2025.
  • 61 funds tracked by Wall St. Rank held Genelux as of Q2 2025.

Based on Miracle Mile Advisors's 13F filing for Q2 2025, filed 22 Jul 2025.